Abstract:The simultaneous use of two or more drugs in clinical treatment may raise the risk of a drug–drug interaction (DDI). DDI prediction is very important to avoid adverse drug events in combination therapy. Recently, deep learning methods have been applied successfully to DDI prediction and improved prediction performance. However, there are still some problems with the present models, such as low accuracy due to information loss during molecular representation or incomplete drug feature mining during the training process. Aiming at these problems, this study proposes an accurate and simple framework named PTB-DDI for drug–drug interaction prediction. The PTB-DDI framework consists of four key modules: (1) ChemBerta tokenizer for molecular representation, (2) Bidirectional Long Short-Term Memory (BiLSTM) to capture the bidirectional context-aware features of drugs, (3) Multilayer Perceptron (MLP) for mining the nonlinear relationship of drug features, and (4) interaction predictor to perform an affine transformation and final prediction. In addition, we investigate the effect of dual-mode on parameter-sharing and parameter-independent within the PTB-DDI framework. Furthermore, we conducted comprehensive experiments on the two real-world datasets (i.e., BIOSNAP and DrugBank) to evaluate PTB-DDI framework performance. The results show that our proposed framework has significant improvements over the baselines based on both datasets. Based on the BIOSNAP dataset, the AUC-ROC, PR-AUC, and F1 scores are 0.997, 0.995, and 0.984, respectively. These metrics are 0.896, 0.873, and 0.826 based on the DrugBank dataset. Then, we conduct the case studies on the three newly approved drugs by the Food and Drug Administration (FDA) in 2024 using the PTB-DDI framework in dual modes. The obtained results indicate that our proposed framework has advantages for predicting drug–drug interactions and that the dual modes of the framework complement each other. Furthermore, a free website is developed to enhance accessibility and user experience.

EMSI-BERT: Asymmetrical Entity-Mask Strategy and Symbol-Insert Structure for Drug-Drug Interaction Extraction Based on BERT.

Extracting Drug-Drug Interactions from Texts with BioBERT and Multiple Entity-Aware Attentions.

IMSE: Interaction Information Attention and Molecular Structure Based Drug Drug Interaction Extraction.

A BERT-based Model for Drug-Drug Interaction Extraction from Drug Labels

BERTChem-DDI : Improved Drug-Drug Interaction Prediction from text using Chemical Structure Information

Dependency-based Long Short Term Memory Network for Drug-Drug Interaction Extraction.

Position-aware Deep Multi-Task Learning for Drug-Drug Interaction Extraction

RANEDDI: Relation-aware Network Embedding for Drug-Drug Interaction Prediction

Towards Incorporating Entity-specific Knowledge Graph Information in Predicting Drug-Drug Interactions

A Sparse Feature Extraction Method with Elastic Net for Drug-Target Interaction Identification.

An attention-based effective neural model for drug-drug interactions extraction

Drug-drug Interaction Extraction via Recurrent Neural Network with Multiple Attention Layers

Drug-drug interaction extraction from biomedical texts based on multi-attention mechanism.

Advancing Drug-Target Interaction prediction with BERT and subsequence embedding

Drug-drug interaction extraction from biomedical literature using support vector machine and long short term memory networks.

Drug Drug Interaction Extraction from Chinese Biomedical Literature Using Distant Supervision

Full-attention Based Drug Drug Interaction Extraction Exploiting User-generated Content

PTB-DDI: an Accurate and Simple Framework for Drug–Drug Interaction Prediction Based on Pre-Trained Tokenizer and BiLSTM Model

Attention-Wrapped Hierarchical BLSTMs for DDI Extraction

BioBERT-based Deep Learning and Merged ChemProt-DrugProt for Enhanced Biomedical Relation Extraction

Two Step Joint Model for Drug Drug Interaction Extraction